LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Icosavax, Inc.…

Similar companies to Icosavax, Inc.

Icosavax, Inc. Tech Stack

Icosavax, Inc. uses 8 technology products and services including Facebook Ads, NVIDIA, Adobe Experience Manager, and more. Explore Icosavax, Inc.'s tech stack below.

  • Facebook Ads
    Advertising
  • NVIDIA
    Audio, Video, Graphics
  • Adobe Experience Manager
    Content Management System
  • Monte Carlo
    Data Management Platforms
  • Azure SQL
    Database
  • Opinio
    Online Form Builders
  • Bottomline Technologies
    Payment Processing
  • HTML5
    Web Tools And Plugins

Media & News

Icosavax, Inc.'s Email Address Formats

Icosavax, Inc. uses at least 2 format(s):
Icosavax, Inc. Email FormatsExamplePercentage
First.Last@icosavax.comJohn.Doe@icosavax.com
97%
F.Last@icosavax.comJ.Doe@icosavax.com
1%
First.MiddleLast@icosavax.comJohn.MichaelDoe@icosavax.com
2%
First.Last@astrazeneca.comJohn.Doe@astrazeneca.com
91%
FirstLast@astrazeneca.comJohnDoe@astrazeneca.com
4%
First_Last@astrazeneca.comJohn_Doe@astrazeneca.com
3%
Last.First@astrazeneca.comDoe.John@astrazeneca.com
2%

Frequently Asked Questions

Where is Icosavax, Inc.'s headquarters located?

Minus sign iconPlus sign iconIcosavax, Inc.'s main headquarters is located at 1930 Boren Ave Suite 1000 Seattle, Washington 98101 US. The company has employees across 1 continents, including North America.

What is Icosavax, Inc.'s official website and social media links?

Minus sign iconPlus sign iconIcosavax, Inc.'s official website is astrazeneca.com and has social profiles on LinkedIn.

What is Icosavax, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign iconIcosavax, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Icosavax, Inc. have currently?

Minus sign iconPlus sign iconAs of September 2024, Icosavax, Inc. has approximately 39 employees across 1 continents, including North America. Key team members include Chief Medical Officer: N. K. M. M.President: S. S.Senior Vice President, Regulatory Affairs: A. S. B.. Explore Icosavax, Inc.'s employee directory with LeadIQ.

What industry does Icosavax, Inc. belong to?

Minus sign iconPlus sign iconIcosavax, Inc. operates in the Biotechnology Research industry.

What technology does Icosavax, Inc. use?

Minus sign iconPlus sign iconIcosavax, Inc.'s tech stack includes Facebook AdsNVIDIAAdobe Experience ManagerMonte CarloAzure SQLOpinioBottomline TechnologiesHTML5.

What is Icosavax, Inc.'s email format?

Minus sign iconPlus sign iconIcosavax, Inc.'s email format typically follows the pattern of First.Last@icosavax.com. Find more Icosavax, Inc. email formats with LeadIQ.

How much funding has Icosavax, Inc. raised to date?

Minus sign iconPlus sign icon As of September 2024, Icosavax, Inc. has raised $68M in funding. The last funding round occurred on May 22, 2023 for $68M.

When was Icosavax, Inc. founded?

Minus sign iconPlus sign iconIcosavax, Inc. was founded in 2018.

Icosavax, Inc.

Biotechnology ResearchWashington, United States11-50 Employees

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle. Icosavax is a member of the AstraZeneca Group.

Section iconCompany Overview

Headquarters
1930 Boren Ave Suite 1000 Seattle, Washington 98101 US
Website
astrazeneca.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $68M

    Icosavax, Inc. has raised a total of $68M of funding over 7 rounds. Their latest funding round was raised on May 22, 2023 in the amount of $68M.

  • $1M$10M

    Icosavax, Inc.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $68M

    Icosavax, Inc. has raised a total of $68M of funding over 7 rounds. Their latest funding round was raised on May 22, 2023 in the amount of $68M.

  • $1M$10M

    Icosavax, Inc.'s revenue is estimated to be in the range of $1M$10M

Company Leadership

  • Stylized image of a person
    N. K. M. M.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. S.
    President
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. S. B.
    Senior Vice President, Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. C.
    Vice President, Clinical Development - Research And Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    K. D.
    Director Of Drug Substance Operations
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    G. K.
    Director Of Quality Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    T. S.
    Director Of Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    E. K.
    Senior Manager Business Operations
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. H.
    Principal
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. W.
    Lc Columns
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.